Argatroban | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Argatroban
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Argatroban

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

22 API Suppliers, 10 USDMF, 6 JDMF, 2 EU WC, 2 KDMF, 7 NDC API, 9 Listed Suppliers, $ API Reference Price

22 API Suppliers
10 USDMF
6 JDMF
2 EU WC
2 KDMF
7 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 19 FDA Orange Book, 2 Europe, 4 Listed Dossiers

25 FDF Dossiers
19 FDA Orange Book
2 Europe
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INJECTION - 50MG/50ML (1MG/ML), INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)
INJECTABLE;INJECTION - 50MG/50ML (1MG/ML)
INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)
INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Actylis, 1 BASF, 1 Finar, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

1 Evonik
1 Rochem International Inc
2 SPI Pharma
1 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
2 Actylis
1 BASF
1 Finar
11 Roquette
1 Shijiazhuang Huaxu Pharmaceutical
1 Valens Pharmachem
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

11 Film Formers & Plasticizers, 5 Parenteral, 4 Taste Masking, 4 Coating Systems & Additives, 4 Fillers, Diluents & Binders, 3 Solubilizers, 3 Topical, 2 Chewable & Orodispersible Aids, 1 Direct Compression, 1 Soft Gelatin, 1 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Co-Processed Excipients

11 Film Formers & Plasticizers
5 Parenteral
4 Taste Masking
4 Coating Systems & Additives
4 Fillers, Diluents & Binders
3 Solubilizers
3 Topical
2 Chewable & Orodispersible Aids
1 Direct Compression
1 Soft Gelatin
1 Emulsifying Agents
1 Thickeners and Stabilizers
1 Co-Processed Excipients

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 10 News #PharmaBuzz

1 Data Compilation #PharmaFlow
10 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices, 3 Annual Reports

2 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

2 USP, 6 Others

2 USP
6 Others

$ API Ref.Price (USD/KG) : 83,296 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2CIPLA

filter Patent Number Reset all filters

2 All

01 17589106

02 17687516

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22027-09-26

Product Main Page

01

CIPLA

ELCC

Not Confirmed

CIPLA

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-09-26

US Patent Number : 7687516

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22434

Patent Use Code : U-1164

Delist Requested :

Patent Use Description : METHOD OF TREATING AN ...

Patent Expiration Date : 2027-09-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

CIPLA

ELCC

Not Confirmed

CIPLA

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-09-26

US Patent Number : 7589106

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22434

Patent Use Code : U-1163

Delist Requested :

Patent Use Description : METHOD OF TREATING THR...

Patent Expiration Date : 2027-09-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!